drugset / Trial / NCT03654664
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to evaluate the immunogenicity and safety after one primary dose and one additional dose of inactivated hepatitis A vaccine are administered in Korean healthy children aged 12-23 months.
Timeline
- Start
- 2017-06-20
- Primary completion
- 2019-06-24
- Completion
- 2019-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Havrix Inj | Vaccine | 0.5 ml | — |
| Subject | Inactivated hepatitis A vaccine | Vaccine | 0.5 ml | — |